Jonathan Kimmelman
Jonathan Kimmelman
Biomedical Ethics, McGill University
Verified email at mcgill.ca - Homepage
Title
Cited by
Cited by
Year
Sunburn and p53 in the onset of skin cancer
A Ziegler, AS Jonason, DJ Leffellt, JA Simon, HW Sharma, J Kimmelman, ...
Nature 372 (6508), 773-776, 1994
16531994
Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments
VC Henderson, J Kimmelman, D Fergusson, JM Grimshaw, DG Hackam
PLoS Med 10 (7), e1001489, 2013
2362013
The Ottawa statement on the ethical design and conduct of cluster randomized trials
C Weijer, JM Grimshaw, MP Eccles, AD McRae, A White, JC Brehaut, ...
PLoS Med 9 (11), e1001346, 2012
1972012
Increasing placebo responses over time in US clinical trials of neuropathic pain
AH Tuttle, S Tohyama, T Ramsay, J Kimmelman, P Schweinhardt, ...
Pain 156 (12), 2616-2626, 2015
1422015
Distinguishing between exploratory and confirmatory preclinical research will improve translation
J Kimmelman, JS Mogil, U Dirnagl
PLoS Biol 12 (5), e1001863, 2014
1382014
Unsuccessful trial accrual and human subjects protections: an empirical analysis of recently closed trials
B Carlisle, J Kimmelman, T Ramsay, N MacKinnon
Clinical Trials 12 (1), 77-83, 2015
1252015
Setting global standards for stem cell research and clinical translation: the 2016 ISSCR guidelines
GQ Daley, I Hyun, JF Apperley, RA Barker, N Benvenisty, AL Bredenoord, ...
Stem cell reports 6 (6), 787-797, 2016
1242016
The therapeutic misconception at 25: treatment, research, and confusion
J Kimmelman
Hastings Center Report 37 (6), 36-42, 2007
1232007
Gene transfer and the ethics of first-in-human research: lost in translation
J Kimmelman
Cambridge University Press, 2010
1102010
Recent developments in gene transfer: risk and ethics
J Kimmelman
Bmj 330 (7482), 79-82, 2005
1012005
Confronting stem cell hype
T Caulfield, D Sipp, CE Murry, GQ Daley, J Kimmelman
Science 352 (6287), 776-777, 2016
892016
Against pandemic research exceptionalism
AJ London, J Kimmelman
Science 368 (6490), 476-477, 2020
872020
Predicting harms and benefits in translational trials: ethics, evidence, and uncertainty
J Kimmelman, AJ London
PLoS Med 8 (3), e1001010, 2011
842011
Helsinki discords: FDA, ethics, and international drug trials
J Kimmelman, C Weijer, EM Meslin
Lancet 373 (9657), 13-14, 2009
822009
Are outcome-adaptive allocation trials ethical?
SP Hey, J Kimmelman
Clinical trials 12 (2), 102-106, 2015
752015
Where have all the rodents gone? The effects of attrition in experimental research on cancer and stroke
C Holman, SK Piper, U Grittner, AA Diamantaras, J Kimmelman, ...
PLoS biology 14 (1), e1002331, 2016
732016
Activating phosphorylation of the Kin28p subunit of yeast TFIIH by Cak1p
J Kimmelman, P Kaldis, CJ Hengartner, GM Laff, SS Koh, RA Young, ...
Molecular and Cellular Biology 19 (7), 4774-4787, 1999
691999
The Structure of Clinical Translation: Efficiency, Information, and Ethics
J Kimmelman, AJ London
Hastings Center Report 45 (2), 27-39, 2015
642015
Beyond access vs. protection in trials of innovative therapies
AJ London, J Kimmelman, ME Emborg
Science 328 (5980), 829-830, 2010
632010
Risking ethical insolvency: a survey of trends in criminal DNA databanking
J Kimmelman
The Journal of Law, Medicine & Ethics 28 (3), 209-221, 2000
632000
The system can't perform the operation now. Try again later.
Articles 1–20